Decreases of Smad3 occurred in diverse types of cancers, including B-cell lymphomas26, gastric cancers28,29, ovarian adenocarcinomas30, prostate carcinomas31, and etc. Smad3 was also shown to suppress liver tumorigenesis by promoting apoptosis in tumor cells5. Here, SMAD3 is linked to neoplasm.